Drug: LUCENTIS Injury: Choroidal neovascularisation Quarter: 2016Q3
Total Records: 5 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125075042 | LUCENTIS | Choroidal neovascularisation | ROCHE | 0.00 | F | 0 | 20160729 | BE |
125981701 | LUCENTIS | Choroidal neovascularisation | ROCHE | 0.00 | M | 0 | 20160727 | JP |
126093141 | LUCENTIS | Choroidal neovascularisation | ROCHE | 50.00 YR | 0 | 20160801 | TW | |
126435041 | LUCENTIS | Choroidal neovascularisation | ROCHE | 74.00 YR | F | 0 | 20160811 | KR |
126896101 | LUCENTIS | Choroidal neovascularisation | ROCHE | 74.35 YR | M | 0 | 20160826 | ZA |
Total Records: 5 Number of Pages: 1